Merck’s Q4 results were marginally above our high expectations, but they beat consensus by 2-4% depending on the level. At the divisional level, the reported pattern fits as well. Management shared its view on the development of the virus outbreak and its expected implications on the detailed, but figure-less, FY guidance, which was much appreciated.
05 Mar 2020
The expected strong set of figures
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
The expected strong set of figures
Merck KGaA (MRCK:WBO) | 0 0 1.2% | Mkt Cap: 10,792m
- Published:
05 Mar 2020 -
Author:
Martin Schnee -
Pages:
3
Merck’s Q4 results were marginally above our high expectations, but they beat consensus by 2-4% depending on the level. At the divisional level, the reported pattern fits as well. Management shared its view on the development of the virus outbreak and its expected implications on the detailed, but figure-less, FY guidance, which was much appreciated.